Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Swartz

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
Schizophrenia Research|September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trialDel D Miller, Joseph P McEvoy, Sonia M Davis, et al.
Community Mental Health Journal|October 12, 2012
Adverse impact of coercive treatments on psychiatric inpatients' satisfaction with careJennifer L Strauss, Jennifer B Zervakis, Karen M Stechuchak, et al.
The American Journal of Psychiatry|March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE studyMarvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Schizophrenia Research|February 9, 2008
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1Jonathan M Meyer, Vicki G Davis, Donald C Goff, et al.
PLOS Mental Health|September 2, 2025
Mental disorders and criminal legal involvement: Evidence from a national diagnostic epidemiological surveyJeffrey W Swanson, Madeline Stenger, Michele M Easter, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease|March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
Schizophrenia Research|January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatmentJoseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Schizophrenia Research|September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trialDel D Miller, Joseph P McEvoy, Sonia M Davis, et al.
Community Mental Health Journal|October 12, 2012
Adverse impact of coercive treatments on psychiatric inpatients' satisfaction with careJennifer L Strauss, Jennifer B Zervakis, Karen M Stechuchak, et al.
The American Journal of Psychiatry|March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE studyMarvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Schizophrenia Research|February 9, 2008
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1Jonathan M Meyer, Vicki G Davis, Donald C Goff, et al.
PLOS Mental Health|September 2, 2025
Mental disorders and criminal legal involvement: Evidence from a national diagnostic epidemiological surveyJeffrey W Swanson, Madeline Stenger, Michele M Easter, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease|March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
Schizophrenia Research|January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatmentJoseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, et al.
Pageof 27